Literature DB >> 15528682

Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults.

James P Watt1, Katherine L O'Brien, Scott Katz, Melinda A Bronsdon, John Elliott, Jean Dallas, Mindy J Perilla, Raymond Reid, Laurel Murrow, Richard Facklam, Mathuram Santosham, Cynthia G Whitney.   

Abstract

Several studies have shown that nasopharyngeal sampling is more sensitive than oropharyngeal sampling for the detection of pneumococcal carriage in children. The data for adults are limited and conflicting. This study was part of a larger study of pneumococcal carriage on the Navajo and White Mountain Apache Reservation following a clinical trial of a seven-valent pneumococcal conjugate vaccine. Persons aged 18 years and older living in households with children enrolled in the vaccine trial were eligible. We collected both nasopharyngeal and oropharyngeal specimens by passing a flexible calcium alginate wire swab either nasally to the posterior nasopharynx or orally to the posterior oropharynx. Swabs were placed in skim milk-tryptone-glucose-glycerin medium and frozen at -70 degrees C. Pneumococcal isolation was performed by standard techniques. Analyses were based on specimens collected from 1,994 adults living in 1,054 households. Nasopharyngeal specimens (11.1%; 95% confidence interval [CI], 9.8 and 12.6%) were significantly more likely to grow pneumococci than were oropharyngeal specimens (5.8%; 95% CI, 4.8 to 6.9%) (P < 0.0001). Few persons had pneumococcal growth from both specimens (1.7%). Therefore, both tests together were more likely to identify pneumococcal carriage (15.2%; 95% CI, 13.7 to 16.9%) than either test alone. Although we found that nasopharyngeal sampling was more sensitive than oropharyngeal sampling, nasopharyngeal sampling alone would have underestimated the prevalence of pneumococcal carriage in this adult population. Sampling both sites may give more accurate results than sampling either site alone in studies of pneumococcal carriage in adults.

Entities:  

Mesh:

Year:  2004        PMID: 15528682      PMCID: PMC525247          DOI: 10.1128/JCM.42.11.4974-4976.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Design of a group-randomized Streptococcus pneumoniae vaccine trial.

Authors:  L H Moulton; K L O'Brien; R Kohberger; I Chang; R Reid; R Weatherholtz; J G Hackell; G R Siber; M Santosham
Journal:  Control Clin Trials       Date:  2001-08

Review 2.  Dynamics of nasopharyngeal colonization by potential respiratory pathogens.

Authors:  J A García-Rodríguez; M J Fresnadillo Martínez
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

3.  Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies.

Authors:  K L O'Brien; M A Bronsdon; R Dagan; P Yagupsky; J Janco; J Elliott; C G Whitney; Y H Yang; L G Robinson; B Schwartz; G M Carlone
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Bacterial flora in the nasopharynx and nasal cavity of healthy young men.

Authors:  J Ylikoski; S Savolainen; H Jousimies-Somer
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1989       Impact factor: 1.538

5.  Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types.

Authors:  J O Hendley; M A Sande; P M Stewart; J M Gwaltney
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

6.  The role of antigen detection in pneumococcal carriers: a comparison between cultures and capsular antigen detection in upper respiratory tract secretions.

Authors:  W G Boersma; A Löwenberg; Y Holloway; H Kuttschrütter; J A Snijder; H Koëter
Journal:  Scand J Infect Dis       Date:  1993

7.  Relationship between colonial morphology and adherence of Streptococcus pneumoniae.

Authors:  D R Cundell; J N Weiser; J Shen; A Young; E I Tuomanen
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

8.  Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group.

Authors:  H M Foy; B Wentworth; G E Kenny; J M Kloeck; J T Grayston
Journal:  Am Rev Respir Dis       Date:  1975-05

9.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

Authors:  Katherine L O'Brien; Lawrence H Moulton; Raymond Reid; Robert Weatherholtz; Jane Oski; Laura Brown; Gaurav Kumar; Alan Parkinson; Diana Hu; Jill Hackell; Ih Chang; Robert Kohberger; George Siber; Mathuram Santosham
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

View more
  39 in total

1.  Sialic acid transport contributes to pneumococcal colonization.

Authors:  Carolyn Marion; Amanda M Burnaugh; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

2.  Mixing of nasopharyngeal and oropharyngeal samples to identify potential respiratory pathogens in adults.

Authors:  D Lieberman; A Shimoni; A Terry; E Shleyfer; H Castel; I Harman-Boehm; N Peled; D Lieberman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

3.  How valid is single-colony isolation for surveillance of Streptococcus pneumoniae carriage?

Authors:  B M Charalambous; Ndekya M Oriyo; S H Gillespie
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

4.  Multiplex Urinary Antigen Detection for 13 Streptococcus pneumoniae Serotypes Improves Diagnosis of Pneumococcal Pneumonia in South African HIV-Infected Adults.

Authors:  Werner C Albrich; Michael W Pride; Shabir A Madhi; Jan Callahan; Peter V Adrian; Roger French; Nadia van Niekerk; Shite Sebastian; Victor Souza; Jean-Noel Telles; Glaucia Paranhos-Baccalà; Kathrin U Jansen; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

5.  Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

Authors:  David B Blossom; Grace Namayanja-Kaye; Joan Nankya-Mutyoba; John B Mukasa; Henry Bakka; Sandra Rwambuya; Anne Windau; Saralee Bajaksouzian; Courtney J Walker; Moses L Joloba; Cissy Kityo; Peter Mugyenyi; Christopher C Whalen; Michael R Jacobs; Robert A Salata
Journal:  Int J Infect Dis       Date:  2006-09-25       Impact factor: 3.623

6.  Streptococcus pneumoniae Colonization Disrupts the Microbial Community within the Upper Respiratory Tract of Aging Mice.

Authors:  Netusha Thevaranjan; Fiona J Whelan; Alicja Puchta; Eta Ashu; Laura Rossi; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

7.  Identification of an ATPase, MsmK, which energizes multiple carbohydrate ABC transporters in Streptococcus pneumoniae.

Authors:  Carolyn Marion; Andrew E Aten; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

8.  Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.

Authors:  Janice L Speshock; Nicole Doyon-Reale; R Rabah; Melody N Neely; Paul C Roberts
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

9.  Growth of Streptococcus pneumoniae on human glycoconjugates is dependent upon the sequential activity of bacterial exoglycosidases.

Authors:  Amanda M Burnaugh; Laura J Frantz; Samantha J King
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

10.  Identification of a pneumococcal glycosidase that modifies O-linked glycans.

Authors:  Carolyn Marion; Dominique H Limoli; Gregory S Bobulsky; Jessica L Abraham; Amanda M Burnaugh; Samantha J King
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.